Quanta (OTCMKTS:QNTA) Stock Falls: Company Schedules Conference Call

Integrated biotech company Medolife Rx Inc was in the news yesterday and that brought the stock of its parent company Quanta Inc into action.

Trading Data

On Wednesday, QNTA stock moved down 8% to $0.0046 with more than 14.93 million shares, compared to its average volume of 3.04 million shares. The stock moved within a range of $0.0044 – 0.0059 after opening trading at $0.0050.

Technical Data

QNTA stock is trading above the 20-Day and 50-Day Moving averages of $0.0049 and $0.0053 respectively. However, the stock is trading below the 200-Day moving average of $0.0209.

Medolife Rx Schedules Conference Call with Investment Community to Discuss New Updates and Answer Questions

Yesterday, the Quanta (OTCMKTS:QNTA) stock decline by as much as 8% following an announcement from Medolife and hence, it could be a good idea for investors to take a look at the actual announcement. Medolife announced yesterday that it had decided to hold a conference call on May 12 with its investors. In addition to that, Medolife also provided the details of the topics that were going to be discussed at the conference call.

It may be a good idea for investors to take a look at some of the topics that are going to be discussed. One of those is with regards to more capital infusion and another important topic is with regards to lobbying the United States Food and Drug Administration. In addition to that, the status with regards to the change of the company’s name and ticker symbol are also going to be matters of discussion. The company is also going to address the concerns that have been raised by investors in recent times.

Key Quote

“We look forward to connecting with our shareholders and provide an update to the Company’s many updates,” said Medolife CEO Dr. Arthur Mikaelian. “The Company has faced many challenges in the recent months that we continue to overcome as we strive toward achieving Medolife’s main goals. We sincerely appreciate the support of our shareholders, and I look forward to providing an informative and comprehensive update clarifying Medolife’s many projects and current strategies.”

Technical Data

QNTA stock is trading above the 20-Day and 50-Day Moving averages of $0.0049 and $0.0053 respectively. However, the stock is trading below the 200-Day moving average of $0.0209.